A Long Non-coding RNA, LOC157273, Is an Effector Transcript at the Chromosome 8p23.1-PPP1R3B Metabolic Traits and Type 2 Diabetes Risk Locus
AimsCausal transcripts at genomic loci associated with type 2 diabetes (T2D) are mostly unknown. The chr8p23.1 variant rs4841132, associated with an insulin-resistant diabetes risk phenotype, lies in the second exon of a long non-coding RNA (lncRNA) gene, LOC157273, located 175 kilobases from PPP1R3...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fgene.2020.00615/full |
id |
doaj-9d4e263c3f284be6a793db9ae92b53aa |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Alisa K. Manning Alisa K. Manning Alisa K. Manning Anton Scott Goustin Erica L. Kleinbrink Pattaraporn Thepsuwan Juan Cai Donghong Ju Donghong Ju Aaron Leong Aaron Leong Aaron Leong Miriam S. Udler Miriam S. Udler James Bentley Brown James Bentley Brown James Bentley Brown Mark O. Goodarzi Jerome I. Rotter Robert Sladek Robert Sladek Robert Sladek James B. Meigs James B. Meigs James B. Meigs Leonard Lipovich Leonard Lipovich |
spellingShingle |
Alisa K. Manning Alisa K. Manning Alisa K. Manning Anton Scott Goustin Erica L. Kleinbrink Pattaraporn Thepsuwan Juan Cai Donghong Ju Donghong Ju Aaron Leong Aaron Leong Aaron Leong Miriam S. Udler Miriam S. Udler James Bentley Brown James Bentley Brown James Bentley Brown Mark O. Goodarzi Jerome I. Rotter Robert Sladek Robert Sladek Robert Sladek James B. Meigs James B. Meigs James B. Meigs Leonard Lipovich Leonard Lipovich A Long Non-coding RNA, LOC157273, Is an Effector Transcript at the Chromosome 8p23.1-PPP1R3B Metabolic Traits and Type 2 Diabetes Risk Locus Frontiers in Genetics insulin resistance hepatic glycogen storage long non-coding RNA metabolism type 2 diabetes regulatory mechanisms |
author_facet |
Alisa K. Manning Alisa K. Manning Alisa K. Manning Anton Scott Goustin Erica L. Kleinbrink Pattaraporn Thepsuwan Juan Cai Donghong Ju Donghong Ju Aaron Leong Aaron Leong Aaron Leong Miriam S. Udler Miriam S. Udler James Bentley Brown James Bentley Brown James Bentley Brown Mark O. Goodarzi Jerome I. Rotter Robert Sladek Robert Sladek Robert Sladek James B. Meigs James B. Meigs James B. Meigs Leonard Lipovich Leonard Lipovich |
author_sort |
Alisa K. Manning |
title |
A Long Non-coding RNA, LOC157273, Is an Effector Transcript at the Chromosome 8p23.1-PPP1R3B Metabolic Traits and Type 2 Diabetes Risk Locus |
title_short |
A Long Non-coding RNA, LOC157273, Is an Effector Transcript at the Chromosome 8p23.1-PPP1R3B Metabolic Traits and Type 2 Diabetes Risk Locus |
title_full |
A Long Non-coding RNA, LOC157273, Is an Effector Transcript at the Chromosome 8p23.1-PPP1R3B Metabolic Traits and Type 2 Diabetes Risk Locus |
title_fullStr |
A Long Non-coding RNA, LOC157273, Is an Effector Transcript at the Chromosome 8p23.1-PPP1R3B Metabolic Traits and Type 2 Diabetes Risk Locus |
title_full_unstemmed |
A Long Non-coding RNA, LOC157273, Is an Effector Transcript at the Chromosome 8p23.1-PPP1R3B Metabolic Traits and Type 2 Diabetes Risk Locus |
title_sort |
long non-coding rna, loc157273, is an effector transcript at the chromosome 8p23.1-ppp1r3b metabolic traits and type 2 diabetes risk locus |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Genetics |
issn |
1664-8021 |
publishDate |
2020-07-01 |
description |
AimsCausal transcripts at genomic loci associated with type 2 diabetes (T2D) are mostly unknown. The chr8p23.1 variant rs4841132, associated with an insulin-resistant diabetes risk phenotype, lies in the second exon of a long non-coding RNA (lncRNA) gene, LOC157273, located 175 kilobases from PPP1R3B, which encodes a key protein regulating insulin-mediated hepatic glycogen storage in humans. We hypothesized that LOC157273 regulates expression of PPP1R3B in human hepatocytes.MethodsWe tested our hypothesis using Stellaris fluorescent in situ hybridization to assess subcellular localization of LOC157273; small interfering RNA (siRNA) knockdown of LOC157273, followed by RT-PCR to quantify LOC157273 and PPP1R3B expression; RNA-seq to quantify the whole-transcriptome gene expression response to LOC157273 knockdown; and an insulin-stimulated assay to measure hepatocyte glycogen deposition before and after knockdown.ResultsWe found that siRNA knockdown decreased LOC157273 transcript levels by approximately 80%, increased PPP1R3B mRNA levels by 1.7-fold, and increased glycogen deposition by >50% in primary human hepatocytes. An A/G heterozygous carrier (vs. three G/G carriers) had reduced LOC157273 abundance due to reduced transcription of the A allele and increased PPP1R3B expression and glycogen deposition.ConclusionWe show that the lncRNA LOC157273 is a negative regulator of PPP1R3B expression and glycogen deposition in human hepatocytes and a causal transcript at an insulin-resistant T2D risk locus. |
topic |
insulin resistance hepatic glycogen storage long non-coding RNA metabolism type 2 diabetes regulatory mechanisms |
url |
https://www.frontiersin.org/article/10.3389/fgene.2020.00615/full |
work_keys_str_mv |
AT alisakmanning alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT alisakmanning alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT alisakmanning alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT antonscottgoustin alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT ericalkleinbrink alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT pattarapornthepsuwan alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT juancai alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT donghongju alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT donghongju alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT aaronleong alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT aaronleong alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT aaronleong alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT miriamsudler alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT miriamsudler alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT jamesbentleybrown alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT jamesbentleybrown alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT jamesbentleybrown alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT markogoodarzi alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT jeromeirotter alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT robertsladek alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT robertsladek alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT robertsladek alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT jamesbmeigs alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT jamesbmeigs alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT jamesbmeigs alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT leonardlipovich alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT leonardlipovich alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT alisakmanning longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT alisakmanning longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT alisakmanning longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT antonscottgoustin longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT ericalkleinbrink longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT pattarapornthepsuwan longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT juancai longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT donghongju longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT donghongju longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT aaronleong longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT aaronleong longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT aaronleong longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT miriamsudler longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT miriamsudler longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT jamesbentleybrown longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT jamesbentleybrown longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT jamesbentleybrown longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT markogoodarzi longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT jeromeirotter longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT robertsladek longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT robertsladek longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT robertsladek longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT jamesbmeigs longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT jamesbmeigs longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT jamesbmeigs longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT leonardlipovich longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus AT leonardlipovich longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus |
_version_ |
1724514370836234240 |
spelling |
doaj-9d4e263c3f284be6a793db9ae92b53aa2020-11-25T03:44:31ZengFrontiers Media S.A.Frontiers in Genetics1664-80212020-07-011110.3389/fgene.2020.00615521982A Long Non-coding RNA, LOC157273, Is an Effector Transcript at the Chromosome 8p23.1-PPP1R3B Metabolic Traits and Type 2 Diabetes Risk LocusAlisa K. Manning0Alisa K. Manning1Alisa K. Manning2Anton Scott Goustin3Erica L. Kleinbrink4Pattaraporn Thepsuwan5Juan Cai6Donghong Ju7Donghong Ju8Aaron Leong9Aaron Leong10Aaron Leong11Miriam S. Udler12Miriam S. Udler13James Bentley Brown14James Bentley Brown15James Bentley Brown16Mark O. Goodarzi17Jerome I. Rotter18Robert Sladek19Robert Sladek20Robert Sladek21James B. Meigs22James B. Meigs23James B. Meigs24Leonard Lipovich25Leonard Lipovich26Clinical and Translational Epidemiology Unit, Mongan Institute, Massachusetts General Hospital, Boston, MA, United StatesDepartment of Medicine, Harvard Medical School, Boston, MA, United StatesPrograms in Metabolism and Medical & Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, United StatesCenter for Molecular Medicine & Genetics, Wayne State University, Detroit, MI, United StatesCenter for Molecular Medicine & Genetics, Wayne State University, Detroit, MI, United StatesCenter for Molecular Medicine & Genetics, Wayne State University, Detroit, MI, United StatesCenter for Molecular Medicine & Genetics, Wayne State University, Detroit, MI, United StatesCenter for Molecular Medicine & Genetics, Wayne State University, Detroit, MI, United StatesKarmanos Cancer Institute at Wayne State University, Detroit, MI, United StatesPrograms in Metabolism and Medical & Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, United StatesCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, United StatesDivision of General Internal Medicine, Massachusetts General Hospital, Boston, MA, United StatesCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, United StatesDiabetes Unit, Massachusetts General Hospital, Boston, MA, United StatesDepartment of Statistics, University of California, Berkeley, Berkeley, CA, United States0Centre for Computational Biology, University of Birmingham, Birmingham, United Kingdom1Computational Biosciences Group, Biosciences Area, Lawrence Berkeley National Laboratory, Berkeley, CA, United States2Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States3The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, United States4Department of Human Genetics, McGill University, Montréal, QC, Canada5Department of Medicine, McGill University, Montréal, QC, Canada6McGill University and Genome Québec Innovation Centre, Montréal, QC, CanadaDepartment of Medicine, Harvard Medical School, Boston, MA, United StatesPrograms in Metabolism and Medical & Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, United StatesDivision of General Internal Medicine, Massachusetts General Hospital, Boston, MA, United StatesCenter for Molecular Medicine & Genetics, Wayne State University, Detroit, MI, United States7Department of Neurology, School of Medicine, Wayne State University, Detroit, MI, United StatesAimsCausal transcripts at genomic loci associated with type 2 diabetes (T2D) are mostly unknown. The chr8p23.1 variant rs4841132, associated with an insulin-resistant diabetes risk phenotype, lies in the second exon of a long non-coding RNA (lncRNA) gene, LOC157273, located 175 kilobases from PPP1R3B, which encodes a key protein regulating insulin-mediated hepatic glycogen storage in humans. We hypothesized that LOC157273 regulates expression of PPP1R3B in human hepatocytes.MethodsWe tested our hypothesis using Stellaris fluorescent in situ hybridization to assess subcellular localization of LOC157273; small interfering RNA (siRNA) knockdown of LOC157273, followed by RT-PCR to quantify LOC157273 and PPP1R3B expression; RNA-seq to quantify the whole-transcriptome gene expression response to LOC157273 knockdown; and an insulin-stimulated assay to measure hepatocyte glycogen deposition before and after knockdown.ResultsWe found that siRNA knockdown decreased LOC157273 transcript levels by approximately 80%, increased PPP1R3B mRNA levels by 1.7-fold, and increased glycogen deposition by >50% in primary human hepatocytes. An A/G heterozygous carrier (vs. three G/G carriers) had reduced LOC157273 abundance due to reduced transcription of the A allele and increased PPP1R3B expression and glycogen deposition.ConclusionWe show that the lncRNA LOC157273 is a negative regulator of PPP1R3B expression and glycogen deposition in human hepatocytes and a causal transcript at an insulin-resistant T2D risk locus.https://www.frontiersin.org/article/10.3389/fgene.2020.00615/fullinsulin resistancehepatic glycogen storagelong non-coding RNAmetabolismtype 2 diabetesregulatory mechanisms |